85 related articles for article (PubMed ID: 20164036)
21. MET receptor is a potential therapeutic target in high grade cervical cancer.
Miekus K; Pawlowska M; Sekuła M; Drabik G; Madeja Z; Adamek D; Majka M
Oncotarget; 2015 Apr; 6(12):10086-101. PubMed ID: 25888626
[TBL] [Abstract][Full Text] [Related]
22. MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.
Luraghi P; Reato G; Cipriano E; Sassi F; Orzan F; Bigatto V; De Bacco F; Menietti E; Han M; Rideout WM; Perera T; Bertotti A; Trusolino L; Comoglio PM; Boccaccio C
Cancer Res; 2014 Mar; 74(6):1857-69. PubMed ID: 24448239
[TBL] [Abstract][Full Text] [Related]
23. Head neck squamous cell carcinoma c-Met⁺ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis.
Sun S; Wang Z
Int J Cancer; 2011 Nov; 129(10):2337-48. PubMed ID: 21225626
[TBL] [Abstract][Full Text] [Related]
24. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
25. Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS).
Ferraro D; Corso S; Fasano E; Panieri E; Santangelo R; Borrello S; Giordano S; Pani G; Galeotti T
Oncogene; 2006 Jun; 25(26):3689-98. PubMed ID: 16462764
[TBL] [Abstract][Full Text] [Related]
26. Methionine dependency of malignant tumors: a possible approach for therapy.
Breillout F; Antoine E; Poupon MF
J Natl Cancer Inst; 1990 Oct; 82(20):1628-32. PubMed ID: 2213904
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
Stabile LP; Lyker JS; Huang L; Siegfried JM
Gene Ther; 2004 Feb; 11(3):325-35. PubMed ID: 14737093
[TBL] [Abstract][Full Text] [Related]
28. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
29. Rhabdomyosarcomagenesis-Novel pathway found.
Asakura A; Rudnicki MA
Cancer Cell; 2003 Dec; 4(6):421-2. PubMed ID: 14706332
[TBL] [Abstract][Full Text] [Related]
30. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
[TBL] [Abstract][Full Text] [Related]
31. Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model.
Yu Y; Merlino G
Cancer Res; 2002 May; 62(10):2951-6. PubMed ID: 12019177
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice.
Seitz G; Pfeiffer M; Fuchs J; Warmann SW; Leuschner I; Vokuhl C; Lang P; Handgretinger R; Armeanu-Ebinger S
Oncol Rep; 2010 Oct; 24(4):1067-72. PubMed ID: 20811690
[TBL] [Abstract][Full Text] [Related]
33. HDAC6 promotes growth, migration/invasion, and self-renewal of rhabdomyosarcoma.
Pham TQ; Robinson K; Xu L; Pavlova MN; Skapek SX; Chen EY
Oncogene; 2021 Jan; 40(3):578-591. PubMed ID: 33199827
[TBL] [Abstract][Full Text] [Related]
34. [Molecular mechanisms regulating metastasis of cancer cells with special emphasis on rhabdomyosarcoma].
Tarnowski M; Grymuła K; Tkacz M; Czerewaty M; Poniewierska-Baran A; Ratajczak MZ
Postepy Hig Med Dosw (Online); 2014 Mar; 68():258-70. PubMed ID: 24662794
[TBL] [Abstract][Full Text] [Related]
35. Human rhabdomyosarcoma cells express functional pituitary and gonadal sex hormone receptors: Therapeutic implications.
Poniewierska-Baran A; Schneider G; Sun W; Abdelbaset-Ismail A; Barr FG; Ratajczak MZ
Int J Oncol; 2016 May; 48(5):1815-24. PubMed ID: 26983595
[TBL] [Abstract][Full Text] [Related]
36. CD147 Promotes Tumorigenesis via Exosome-Mediated Signaling in Rhabdomyosarcoma.
Fahs A; Hussein N; Zalzali H; Ramadan F; Ghamloush F; Tamim H; El Homsi M; Badran B; Boulos F; Tawil A; Ghayad SE; Saab R
Cells; 2022 Jul; 11(15):. PubMed ID: 35892564
[TBL] [Abstract][Full Text] [Related]
37. MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression.
Perrone C; Pomella S; Cassandri M; Pezzella M; Milano GM; Colletti M; Cossetti C; Pericoli G; Di Giannatale A; de Billy E; Vinci M; Petrini S; Marampon F; Quintarelli C; Taulli R; Roma J; Gallego S; Camero S; Mariottini P; Cervelli M; Maestro R; Miele L; De Angelis B; Locatelli F; Rota R
Front Oncol; 2022; 12():835642. PubMed ID: 35574376
[TBL] [Abstract][Full Text] [Related]
38. Monosialoganglioside biosynthesis by subcellular membranes of rhabdomyosarcoma cell lines differing in metastatic potential.
Liepkans VA
Int J Cancer; 1990 May; 45(5):961-7. PubMed ID: 2335400
[TBL] [Abstract][Full Text] [Related]
39. Advances in pediatric rhabdomyosarcoma characterization and disease model development.
O'Brien D; Jacob AG; Qualman SJ; Chandler DS
Histol Histopathol; 2012 Jan; 27(1):13-22. PubMed ID: 22127592
[TBL] [Abstract][Full Text] [Related]
40. Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma.
Timpanaro A; Piccand C; Uldry AC; Bode PK; Dzhumashev D; Sala R; Heller M; Rössler J; Bernasconi M
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]